Lates News

Hony announced on the Hong Kong Stock Exchange that its subsidiary Hony Pharmaceuticals has signed a strategic cooperation agreement with AstraZeneca to jointly advance clinical research on a new targeted immunotherapy for the treatment of non-small cell lung cancer.